AC
Achieve Life Sciences, Inc.
ACHV · NASDAQ
$8.05 +2.16% (+$0.17)
1M +0.50%
Market Cap $747.4M
P/E Ratio -
Div. Yield -
ROE 892.07%
Bulios Fair Price
$7.28
9.6% downside
Current Price
$8.05
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ACHV is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
-
N/A EV/EBITDA N/A
P/S N/A
P/B N/A
Growth
100 /100
Growing Book val. growth 37.36%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 892.07%
ROA 59.88%
Asset turnover 0.00x
Debt
15 /100
High Int. coverage -113.73x
Current ratio 0.95x
Net debt/EBITDA N/A
Stability
28 /100
Unstable EPS volatility 32.34%
Profitable years 0
Beta 2.25x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ACHV
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Andrew D. Goldberg
Employees
28
Headquarters
Bothell
Upcoming events
05 NOV
Earnings
Upcoming earnings report